Fundraising FoxBrenig Therapeutics, Inc.
Dover, US · Founded 2021 · Delaware corporation · 2 known investors
Find your way into Brenig Therapeutics, Inc.
Sign up to find every way you can get introduced to Brenig Therapeutics, Inc.
- Your email: who you already know at Brenig Therapeutics, Inc., and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Brenig Therapeutics, Inc. team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Founders & leadership
ID
Iain DukesNamed on SEC filing
NS
Nikolay SavchukNamed on SEC filing
Board
KG
Keno GutierrezBoard director
EM
MC
Michele CuculluBoard director
Investors · 2
New Enterprise Associates (NEA)reportedMenlo Park · $200K – $40M
How we know: a partner's Signal profile · funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$30M disclosed across 1 round · 2024
▶$30MraisedJul 2024 · 6 investors · BiotechnologyRule 506(b)
▶$30MraisedJul 2024 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Keno GutierrezDirector
- Iain DukesExecutive Officer, Director
- Edward MathersDirector
- Nikolay SavchukExecutive Officer, Director
- Michele CuculluDirector
- Offering amount
- $65M
- Amount sold
- $30M
- First sale
- Jul 2024
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Brenig Therapeutics, Inc.'s investors?
- Brenig Therapeutics, Inc.'s investors include NEA Secondary, New Enterprise Associates (NEA).
- How much funding has Brenig Therapeutics, Inc. raised?
- Brenig Therapeutics, Inc. has disclosed $30M raised across 1 round.
- Where is Brenig Therapeutics, Inc. headquartered?
- Brenig Therapeutics, Inc. is headquartered in Dover, US.